These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28744693)

  • 1. VEGFA Involves in the Use of Fluvastatin and Zoledronate Against Breast Cancer.
    Pu H; Zhang Q; Zhao C; Shi L; Wang Y; Wang J; Zhang M
    Pathol Oncol Res; 2018 Jul; 24(3):557-565. PubMed ID: 28744693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid.
    Dedes PG; Gialeli Ch; Tsonis AI; Kanakis I; Theocharis AD; Kletsas D; Tzanakakis GN; Karamanos NK
    Biochim Biophys Acta; 2012 Dec; 1820(12):1926-39. PubMed ID: 22884656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.
    Qiao H; Wang TY; Yan W; Qin A; Fan QM; Han XG; Wang YG; Tang TT
    Acta Pharmacol Sin; 2015 Sep; 36(9):1085-98. PubMed ID: 26235741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome analysis and in vivo activity of fluvastatin versus zoledronic acid in a murine breast cancer metastasis model.
    Vintonenko N; Jais JP; Kassis N; Abdelkarim M; Perret GY; Lecouvey M; Crepin M; Di Benedetto M
    Mol Pharmacol; 2012 Sep; 82(3):521-8. PubMed ID: 22723339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of the mevalonate pathway as potential therapeutic agents in multiple myeloma.
    Baulch-Brown C; Molloy TJ; Yeh SL; Ma D; Spencer A
    Leuk Res; 2007 Mar; 31(3):341-52. PubMed ID: 16996129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-β-induced expression of VEGFA.
    Jayaraman S; Doucet M; Kominsky SL
    Oncotarget; 2017 Jan; 8(4):6169-6178. PubMed ID: 28008154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor Effects of Ruyiping on Cell Growth and Metastasis in Breast Cancer.
    Li Z; Sun X; Liu X; Sun Z; Li J
    Cancer Biother Radiopharm; 2019 Jun; 34(5):297-305. PubMed ID: 30901274
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway.
    Zhang W; Wu J; Zhou L; Xie HY; Zheng SS
    Indian J Exp Biol; 2010 Dec; 48(12):1167-74. PubMed ID: 21250597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin-induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: intermediacy of nitric oxide and antioxidant defence mechanisms.
    Kanugula AK; Gollavilli PN; Vasamsetti SB; Karnewar S; Gopoju R; Ummanni R; Kotamraju S
    FEBS J; 2014 Aug; 281(16):3719-38. PubMed ID: 24964743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Integrated Systems Biology and Network-Based Approaches to Identify Novel Biomarkers in Breast Cancer Cell Lines Using Gene Expression Data.
    Khan A; Rehman Z; Hashmi HF; Khan AA; Junaid M; Sayaf AM; Ali SS; Hassan FU; Heng W; Wei DQ
    Interdiscip Sci; 2020 Jun; 12(2):155-168. PubMed ID: 32056139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents.
    Budman DR; Calabro A
    Oncology; 2006; 70(2):147-53. PubMed ID: 16645328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
    Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
    Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
    Zhang L; Zhang X; Zhang H; Liu F; Bi Y; Zhang Y; Cheng C; Liu J
    Breast Cancer; 2020 May; 27(3):464-476. PubMed ID: 31919642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTEN Inhibits Tumor Angiogenesis and Growth by Targeting VEGFA Through Down-Regulation of β-Catenin in Breast Cancer.
    Lu X; Zhou B; Cao M; Shao Q; Pan Y; Zhao T
    Technol Cancer Res Treat; 2021; 20():15330338211045506. PubMed ID: 34817293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth inhibitor affects the invasion, apoptosis and vascularisation in breast cancer cell line MDA-MB-231.
    Gao Y; Ge Z; Zhang Z; Bai Z; Ma X; Wang Y
    Chin Med J (Engl); 2014; 127(10):1947-53. PubMed ID: 24824261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway.
    Wang B; Yan Y; Zhou J; Zhou Q; Gui S; Wang Y
    Biomed Pharmacother; 2013 Jun; 67(5):357-62. PubMed ID: 23602051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terrein inhibits migration of human breast cancer cells via inhibition of the Rho and Rac signaling pathways.
    Kasorn A; Loison F; Kangsamaksin T; Jongrungruangchok S; Ponglikitmongkol M
    Oncol Rep; 2018 Mar; 39(3):1378-1386. PubMed ID: 29328460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvastatin inhibits growth and alters the malignant phenotype of the C6 glioma cell line.
    Sławińska-Brych A; Zdzisińska B; Kandefer-Szerszeń M
    Pharmacol Rep; 2014 Feb; 66(1):121-9. PubMed ID: 24905317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
    Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
    Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay.
    Knight LA; Kurbacher CM; Glaysher S; Fernando A; Reichelt R; Dexel S; Reinhold U; Cree IA
    BMC Cancer; 2009 Jan; 9():38. PubMed ID: 19175937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.